Pregled bibliografske jedinice broj: 481943
Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin
Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin // Book of Abstracts / Kovarik, Zrinka ; Varljen, Jadranka (ur.).
Rijeka: Hrvatsko Društvo za Biotehnologiju, 2010. str. 106-106 (poster, nije recenziran, sažetak, znanstveni)
CROSBI ID: 481943 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Liver fibrosis in mice induced by carbon tetrachloride and its reversion by luteolin
Autori
Domitrović, Robert ; Jakovac, Hrvoje ; Tomac, Jelena ; Šain, Ivana ; Tadić, Žarko
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Book of Abstracts
/ Kovarik, Zrinka ; Varljen, Jadranka - Rijeka : Hrvatsko Društvo za Biotehnologiju, 2010, 106-106
Skup
10th Congress of the Croatian Society of Biochemistry and Molecular Biology with International Participation - HDBMB2010
Mjesto i datum
Opatija, Hrvatska, 15.09.2010. - 18.09.2010
Vrsta sudjelovanja
Poster
Vrsta recenzije
Nije recenziran
Ključne riječi
liver fibrosis; carbon tetrachloride; oxidative stress; hepatic stellate cells; luteolin
Sažetak
Hepatic fibrosis is effusive wound healing process in which excessive connective tissue builds up in the liver. Because specific treatments to stop progressive fibrosis of the liver are not available, we have investigated the effects of luteolin on carbon tetrachloride (CCl4)-induced hepatic fibrosis. Male Balb/C mice were treated with CCl4 (20% CCl4 in olive oil, 2 mL/kg) intraperitoneally (i.p.), twice a week for 6 weeks. Luteolin was administered i.p. once daily for next 2 weeks, in doses of 10, 25, and 50 mg/kg of body weight. The CCl4 control group has been observed for spontaneous reversion of fibrosis. CCl4-intoxication increased serum aminotransferase and alkaline phosphatase levels and disturbed hepatic antioxidative status. Most of these parameters were spontaneously normalized in the CCl4 control group, although the progression of liver fibrosis was observed histologically. Luteolin treatment has increased hepatic matrix metalloproteinase-9 levels and metallothionein (MT) I/II expression, eliminated fibrinous deposits and restored architecture of the liver in a dose-dependent manner. Concomitantly, the expression of glial fibrillary acidic protein and α-smooth muscle actin indicated deactivation of hepatic stellate cells. Our results suggest the therapeutic effects of luteolin on CCl4-induced liver fibrosis by promoting extracellular matrix degradation in the fibrotic liver tissue and the strong enhancement of hepatic regenerative capability.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Farmacija
POVEZANOST RADA
Projekti:
062-0000000-3554 - Aktivni sastojci ljekovitog bilja u terapiji fibroze jetre (Domitrović, Robert, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Rijeka